Tablets & Capsules

TC1014B

Issue link: https://www.e-digitaleditions.com/i/398011

Contents of this Issue

Navigation

Page 54 of 65

Tablets & Capsules October 2014 41 ing and Exposition, San Antonio, TX. 2. Sugisawa et al. Comparative Evaluation of Tablet Properties pre- pared with Hydroxypropyl Cellulose and Polyvinylpyrrolidone by Fluidized Bed Granulation Method. 2012 AAPS Annual Meeting and Exposition, Chicago, IL. 3. Sugisawa et al. Comparative Evaluation of Tablet Properties Pre - pared by New Super Fine Powder, Special Low Viscosity Grade of Hydroxypropyl Cellulose (HPC-SSL- SFP). 39th Annual Meeting and Exposition of the Controlled Release Society, Quebec City, Canada, July 2012. 4. Sugisawa et al. Application of Super Fine Powder, Special Low Vis - cosity Hydroxypropyl Cellulose (HPC-SSL-SFP) to Orally Disin te - grating Tablet. 2012 AAPS Annual Meeting and Exposition, Chicago, IL. 5. Sugisawa et al. Application of Super Fine Powder, Special Low Viscosity Grade of Hydroxypropyl Cellulose (HPC-SSL-SFP) to "Tablet Hardness Enhancer" for Hydrophilic Matrix Formulation. 2013 AAPS Annual Meeting and Exposition, San Antonio, TX. 6. Sugisawa et al. Evaluation of Hydroxypropyl Cellulose for the Purpose of Design and Preparation of Orally Disintegrating Film Drug Application. 2013 AAPS Annual Meet ing and Exposition, Chicago, IL. 7. Sarode et al. Low-viscosity hy - droxypropylcellulose (HPC) grades SL and SSL: Versatile pharmaceutical polymers for dissolution enhance- ment, controlled release, and phar- maceutical processing. AAPS Pharm - SciTech, 2013, 14, 151-159. 8. Sarode et al. Hydroxypropyl cel lulose stabilizes amorphous solid dispersions of the poorly water solu- ble drug felodipine. Carbohyd Polym, 2014, 112, 512-519. 9. Bhakay et al. Recovery of BCS Class II drugs during aqueous redis- perion of core-shell type nanocomp- site particles produced via fluidized bed coating. Powder Technol, 2013, 236, 221-234. 10. Bhakay et al. Redispersible fast dissolving nanocomposite micropar- ticles of poorly water-soluble drugs. Int J Pharm, 2014, 461, 367-379. Ryan Cheng is business development spe- cialist at Nisso America, 88 Pine Street, 14th floor, New York, NY 10005. Tel. 212 490 0350, fax 212 972 9361. Website: www.nissoexcipients.com. 6826 State Highway 12, Nor wich, NY 13815 from Norwich Pharma Services DEVELOPMENT MANUFAC TURING CLINICAL RESEARCH FROM A SINGLE PROVIDER CONTRACT CONTRACT CONTRACT S y n c h r o n i z e y o u r n e x t p r o j e c t ยป n o r w i c h p h a r m a . c o m 5 1 8 3 Y 1 , N h c i w r o , N 2 y 1 a w h g i e H t a t 6 S 2 8 6 Need info? New subscriber? Find past articles at www.tabletscapsules.com. Click on Article index

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC1014B